Prevention of acute coronary syndrome by aspirin in patients with breast cancer.
Phase 4
- Conditions
- Health Condition 1: null- Breast Cancer
- Registration Number
- CTRI/2014/12/005235
- Lead Sponsor
- Prof Asru K Sinha DSc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 1140
Inclusion Criteria
1. Breast cancer was diagnosed by mammogram followed by biopsy carried out by professional pathologists.
2. Patients were categorized by TNM (tumor size, no. of nodes & metastasis) classification at presentation.
3. Patients willing to give consent and agreed to obtain judicial affidavit from the court of law and signed informed consent form were included in the study.
Exclusion Criteria
1. Institutionalized patients,
2. History of diabetes mellitus,
3. Systemic hypertension,
4. Severe infections,
5. Life-threatening cardiovascular diseases,
6. Cerebrovascular conditions,
7. Bundle branch block or left-ventricular hypertrophy as shown in EKG.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of deaths due to ACS/AMI in breast cancer patients.Timepoint: 2years
- Secondary Outcome Measures
Name Time Method 1. Development of hypertension every 3months for 2years. <br/ ><br>2. Plasma glucose levels every 4 weeks for 2 years.Timepoint: 2 years